117 related articles for article (PubMed ID: 14758731)
1. CD44 family and gynaecological cancer.
Makrydimas G; Zagorianakou N; Zagorianakou P; Agnantis NJ
In Vivo; 2003; 17(6):633-40. PubMed ID: 14758731
[TBL] [Abstract][Full Text] [Related]
2. Adhesion proteins in the biology of breast cancer: contribution of CD44.
Herrera-Gayol A; Jothy S
Exp Mol Pathol; 1999 Jun; 66(2):149-56. PubMed ID: 10409443
[TBL] [Abstract][Full Text] [Related]
3. Splice variant expression of CD44 in patients with breast and ovarian cancer.
Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
[TBL] [Abstract][Full Text] [Related]
4. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions.
Bajorath J
Proteins; 2000 May; 39(2):103-11. PubMed ID: 10737932
[TBL] [Abstract][Full Text] [Related]
5. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
6. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
[TBL] [Abstract][Full Text] [Related]
7. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
Wang SJ; Wreesmann VB; Bourguignon LY
Head Neck; 2007 Jun; 29(6):550-8. PubMed ID: 17252589
[TBL] [Abstract][Full Text] [Related]
8. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness.
Herrera-Gayol A; Jothy S
Exp Mol Pathol; 1999 Apr; 66(1):99-108. PubMed ID: 10331969
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronidase can modulate expression of CD44.
Stern R; Shuster S; Wiley TS; Formby B
Exp Cell Res; 2001 May; 266(1):167-76. PubMed ID: 11339835
[TBL] [Abstract][Full Text] [Related]
10. CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis.
Peng ST; Su CH; Kuo CC; Shaw CF; Wang HS
Int J Oncol; 2007 Nov; 31(5):1119-26. PubMed ID: 17912438
[TBL] [Abstract][Full Text] [Related]
11. Distribution and expression of CD44 isoforms and Ezrin during prostate cancer-endothelium interaction.
Harrison GM; Davies G; Martin TA; Jiang WG; Mason MD
Int J Oncol; 2002 Nov; 21(5):935-40. PubMed ID: 12370738
[TBL] [Abstract][Full Text] [Related]
12. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
[TBL] [Abstract][Full Text] [Related]
13. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
[TBL] [Abstract][Full Text] [Related]
14. Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44.
Chiu RK; Droll A; Dougherty ST; Carpenito C; Cooper DL; Dougherty GJ
Exp Cell Res; 1999 Apr; 248(1):314-21. PubMed ID: 10094837
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases.
Gee K; Kryworuchko M; Kumar A
Arch Immunol Ther Exp (Warsz); 2004; 52(1):13-26. PubMed ID: 15053229
[TBL] [Abstract][Full Text] [Related]
16. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas.
Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW
Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634
[TBL] [Abstract][Full Text] [Related]
17. The role of CD44 adhesion molecule in oral cavity cancer.
Georgolios A; Batistatou A; Charalabopoulos A; Manolopoulos L; Charalabopoulos K
Exp Oncol; 2006 Jun; 28(2):94-8. PubMed ID: 16837897
[TBL] [Abstract][Full Text] [Related]
18. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
Backhus LM; Sievers E; Lin GY; Castanos R; Bart RD; Starnes VA; Bremner RM
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):297-303. PubMed ID: 16872953
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies with defined recognition sequences in the stem region of CD44: detection of differential glycosylation of CD44 between tumor and stromal cells in tissue.
Matsuki H; Yonezawa K; Obata K; Iwata K; Nakamura H; Okada Y; Seiki M
Cancer Res; 2003 Dec; 63(23):8278-83. PubMed ID: 14678986
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells.
Muthukumaran N; Miletti-González KE; Ravindranath AK; Rodríguez-Rodríguez L
Mol Cancer Res; 2006 Aug; 4(8):511-20. PubMed ID: 16908592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
